SEARCH

SEARCH BY CITATION

References

  • 1
    Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657686.
  • 2
    Bauernfeind A, Horl G. Novel R-factor borne β-lactamase of Escherichia coli confering resistance to cephalosporins. Infection 1987; 15: 257259.
  • 3
    Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 1989; 17: 316321.
  • 4
    Jacoby GA. AmpC β-lactamases. Clin Microbiol Rev 2009; 22: 161182.
  • 5
    Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159166.
  • 6
    Pitout JD, Gregson DB, Church DL, Laupland KB. Population-based laboratory surveillance for AmpC β-lactamase-producing Escherichia coli, Calgary. Emerg Infect Dis 2007; 13: 443448.
  • 7
    Sidjabat HE, Paterson DL, Qureshi ZA et al. Clinical features and molecular epidemiology of CMY-type β-lactamase-producing Escherichia coli. Clin Infect Dis 2009; 48: 739744.
  • 8
    Hanson ND, Moland ES, Hong SG et al. Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob Agents Chemother 2008; 52: 38143816.
  • 9
    Kang CI, Kim SH, Park WB et al. Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 2004; 48: 45744581.
  • 10
    Rodriguez-Bano J, Navarro MD, Romero L et al. Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 2006; 43: 14071414.
  • 11
    Rodriguez-Bano J, Alcalá JC, Cisneros JM et al. Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Arch Intern Med 2008; 168: 18971902.
  • 12
    Rodriguez-Bano J, Navarro MD, Romero L et al. Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42: 10891094.
  • 13
    Carattoli A. Animal reservoirs for extended spectrum β-lactamase producers. Clin Microbiol Infect 2008; 14 (suppl 1): 117123.
  • 14
    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Wayne, PA: CLSI, 2006.
  • 15
    Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 21532162.
  • 16
    Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309332.
  • 17
    Friedman ND, Kaye KS, Stout JE et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791797.
  • 18
    Garcia Dde O, Doi Y, Szabo D et al. Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum β-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil. Antimicrob Agents Chemother 2008; 52: 17901793.
  • 19
    Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 45554558.
  • 20
    Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 22332239.
  • 21
    Wiener J, Quinn JP, Bradford PA et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517523.
  • 22
    Trick WE, Weinstein RA, DeMarais PL et al. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 2001; 49: 270276.
  • 23
    Rodríguez-Baño J, Alcalá J, Cisneros JM et al. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. J Antimicrob Chemother 2009; 63: 781784.
  • 24
    Li XZ, Mehrotra M, Ghimire S et al. β-Lactam resistance and β-lactamases in bacteria of animal origin. Vet Microbiol 2007; 121: 197214.
  • 25
    Jouini A, Vinue L, Slama KB et al. Characterization of CTX-M and SHV extended-spectrum β-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J Antimicrob Chemother 2007; 60: 11371141.
  • 26
    Mesa RJ, Blanc V, Blanch AR et al. Extended-spectrum β-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). J Antimicrob Chemother 2006; 58: 211215.
  • 27
    Jensen LB, Hasman H, Agerso Y et al. First description of an oxyimino-cephalosporin-resistant, ESBL-carrying Escherichia coli isolated from meat sold in Denmark. J Antimicrob Chemother 2006; 57: 793794.
  • 28
    Warren RE, Ensor VM, O’Neill P et al. Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 2008; 61: 504508.
  • 29
    Johnson JR, Sannes MR, Croy C et al. Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002–2004. Emerg Infect Dis 2007; 13: 838846.
  • 30
    Johnson JR, McCabe JS, White DG et al. Molecular analysis of Escherichia coli from retail meats (2002–2004) from the United States National Antimicrobial Resistance Monitoring System. Clin Infect Dis 2009; 49: 195201.
  • 31
    Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors, and molecular epidemiology. J Antimicrob Chemother 2008; 62: 11421149.